how to keep the weight off after stopping semaglutide Will I Semaglutide? Woman shares journey of weight

Ann Oncol 2015;26(8):16351648

The market for obesity drugs might not be as large as previously expected, HSBC cautioned last month, as it recommended clients sell Lilly stock which has significantly outperformed Novo over the past 18 months

Participants were prescribed either semaglutide (oral or subcutaneous) or tirzepatide (subcutaneous) between 2018 and 2024

IF YOU HAVE ANY QUESTIONS AS TO THE RISKS OR HAZARDS OF THIS TREATMENT, OR ANY QUESTIONS CONCERNING THIS PROPOSED TREATMENT OR OTHER POSSIBLE TREATMENTS, ASK THE MEDICAL PROVIDER BEFORE BEGINNING TREATMENT

Do not self-diagnose

After that, Eli Lilly needs to compile the data and submit a New Drug Application to the FDA in the US